Taxotere Off-Label Claims Not Time-Barred, Aren’t Free Speech, Judge Says
PHILADELPHIA — A False Claims Act lawsuit alleging off-label marketing of the chemotherapy drug Taxotere is not barred by the statute of limitations and is not aimed at “truthful, non-misleading” speech...To view the full article, register now.
Already a subscriber? Click here to view full article